Official Positions for FRAX® Clinical Regarding Smoking
| Autor: | David Kendler, Jan Stepan, Michael McClung, Alireza Moayyeri, Robert Daniel Blank |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Fracture risk
medicine.medical_specialty FRAX business.industry Endocrinology Diabetes and Metabolism medicine.medical_treatment Osteoporosis Context (language use) medicine.disease Epidemiology medicine Physical therapy Smoking cessation Radiology Nuclear Medicine and imaging Orthopedics and Sports Medicine Risk factor Risk assessment business Demography |
| Zdroj: | Journal of Clinical Densitometry. 14:190-193 |
| ISSN: | 1094-6950 |
| DOI: | 10.1016/j.jocd.2011.05.011 |
| Popis: | The worldwide prevalence of smoking has been estimated at about 50% in men, and 10% in women, with larger variations among different populations studied. Smoking has been shown to affect many organ systems resulting in severe morbidity and increased mortality. In addition, smoking has been identified as a predictor of ten-year fracture risk in men and women, largely independent of an individual's bone mineral density. This finding has eventually lead to incorporation of this risk factor into FRAX®, an algorithm that has been developed to calculate an individual's ten-year fracture risk. However, only little, or conflicting data is available on a possible association between smoking dose, duration, length of time after cessation, type of tobacco and fracture risk, limiting this risk factor's applicability in the context of FRAX®. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|